Racial Disparities in Utilization of Medications and Disease Outcomes in Inflammatory Bowel Disease Patients.

ABSTRACT:

Background

Although traditionally associated with White European ancestry, inflammatory bowel disease (IBD) has increased among different races and ethnicities. Large studies conducted in the United States and Canada have identified more complex disease phenotypes among Black patients. Our study aimed to investigate disparities in IBD treatments and outcomes between Black and White patients in the United States.

Methods

Using the TriNetX database, adult IBD patients were divided into 2 groups based on race: Black and White patients with IBD, Crohn's disease (CD), or ulcerative colitis (UC). Medical therapy and disease outcomes were evaluated in both groups with 1:1 propensity-score matching. Methodologic limitations include the potential for missing data, lack of information

SUBMITTER: Alsabbagh Alchirazi K 

PROVIDER: S-EPMC12010087 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature